Linden Capital-backed RQM+ completed the acquisition of Jordi Labs.

Linden Capital-backed RQM+, a MedTech service provider, completed the acquisition of Jordi Labs, a provider of laboratory testing services intended to serve polymers, medical devices and pharma industries. Financial terms were not disclosed. “As the only MedTech service provider rooted in almost 40 years of regulatory strategy, RQM+ is proud to now offer proprietary testing services for extractables and leachables, which gives our customers the fastest path to regulatory approvals. We are relentlessly focused on being the best at every service we provide to MedTech manufacturers. Jordi’s world-leading testing services will help us maintain our uncompromising quality standards at every stage as we grow into a one-stop-shop to expedite patient access to life-improving technologies," Margaret Keegan, RQM+ CEO.